ADMA Biologics, Inc.

Contributing Author

Recent Articles by ADMA Biologics, Inc.

Mar-27	ADMA Biologics Issues Statement Refuting Unsubstantiated, Misleading and Inaccurate Allegations by Culper Research ADMA +11.58% GlobeNewswire
Mar-25	ADMA Biologics Addresses Misleading Short-Seller Report ADMA -15.00% GlobeNewswire
Mar-02	ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative ADMA +6.49% GlobeNewswire
Feb-25	ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update ADMA GlobeNewswire
Feb-18	ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 ADMA GlobeNewswire
Jan-12	ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update ADMA GlobeNewswire
Jan-05	ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026 ADMA GlobeNewswire
Nov-05	ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update ADMA -8.72% ADMA +5.06% GlobeNewswire
Oct-29	ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025 ADMA GlobeNewswire
Aug-06	ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update ADMA -9.65% ADMA GlobeNewswire
Jul-30	ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025 ADMA GlobeNewswire
May-07	ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update ADMA -10.21% ADMA GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)